JOSEPH KRAKOWIAK: Open Payments
NPI 1518316041 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 17 payments from 9 companies in 2025. Trend: 2023 $545 · 2024 $578 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $104 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Novo Nordisk Inc | 2 | $34 |
| Organon LLC | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $15 |
Products named: PIFELTRO, DOVATO, FARXIGA, NEXPLANON, VRAYLAR, Kerendia, CABENUVA, BREZTRI.
Industry payments across GA — which companies pay providers there.
